KLEANTHIS G XANTHOPOULOS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KLEANTHIS G XANTHOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KLEANTHIS G XANTHOPOULOS. KLEANTHIS G XANTHOPOULOS is Director in APRICUS BIOSCIENCES, INC. ($APRI) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN).
Latest Insider Trading Transactions of KLEANTHIS G XANTHOPOULOS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RGLS, SEEL, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.93 | 30,000 | 27,954 | 30,000 | |
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 15,000 | 0 | 23,596 | 8.6 K to 23.6 K (+174.50 %) |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Grant | A | 0.00 | 7,500 | 0 | 8,596 | 1.1 K to 8.6 K (+684.31 %) | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| Jul 18 2019 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.34 | 1,500 | 3,510 | 1,500 | |
| Jun 01 2018 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
| Mar 02 2018 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.53 | 30,000 | 15,900 | 30,000 | |
| Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.11 | 50,000 | 105,500 | 50,000 | |
| Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 15,000 | 0 | 24,575 | 9.6 K to 24.6 K (+156.66 %) |
| Nov 04 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.58 | 20,000 | 11,500 | 20,000 | |
| Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.34 | 16,997 | 5,750 | 95,746 | 78.7 K to 95.7 K (+21.58 %) |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | P | 1.55 | 15,920 | 24,676 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | P | 1.45 | 15,920 | 23,084 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Buy | P | 1.32 | 15,920 | 21,014 | 21,920 | 6 K to 21.9 K (+265.33 %) |
| Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.40 | 14,393 | 5,750 | 78,749 | 64.4 K to 78.7 K (+22.36 %) |
| Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.58 | 8,621 | 5,000 | 64,356 | 55.7 K to 64.4 K (+15.47 %) |
| Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.97 | 50,000 | 48,500 | 50,000 | |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 60,000 | 22,800 | 8,287 | |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 66,071 | 25,107 | 68,287 | |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 73,929 | 28,093 | 134,358 | |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 17.73 | 60,000 | 1,063,980 | 3,705 | 63.7 K to 3.7 K (-94.18 %) |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 60,000 | 22,800 | 63,705 | 3.7 K to 63.7 K (+1,619.43 %) |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 16.85 | 66,071 | 1,113,514 | 3,705 | 69.8 K to 3.7 K (-94.69 %) |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 66,071 | 25,107 | 69,776 | 3.7 K to 69.8 K (+1,783.29 %) |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 16.94 | 73,929 | 1,252,002 | 3,705 | 77.6 K to 3.7 K (-95.23 %) |
| Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 73,929 | 28,093 | 77,634 | 3.7 K to 77.6 K (+1,995.38 %) |
| Apr 02 2015 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 89,230 | 33,907 | 208,287 | |
| Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.81 | 23,616 | 491,551 | 2,466 | 26.1 K to 2.5 K (-90.55 %) |
| Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.06 | 65,614 | 1,316,512 | 26,082 | 91.7 K to 26.1 K (-71.56 %) |
| Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 89,230 | 33,907 | 91,696 | 2.5 K to 91.7 K (+3,618.41 %) |
| Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 70 | 27 | 297,517 | |
| Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.50 | 70 | 1,365 | 2,466 | 2.5 K to 2.5 K (-2.76 %) |
| Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 70 | 27 | 2,536 | 2.5 K to 2.5 K (+2.84 %) |
Page: 1